Suscribirse

Low incidence and high remission of allergic sensitization among adults - 24/12/11

Doi : 10.1016/j.jaci.2011.08.033 
Katja Warm, MD a, b, c, Helena Backman, BSc a, Anne Lindberg, MD, PhD a, c, Bo Lundbäck, MD, PhD a, d, Eva Rönmark, PhD a, c,
a Obstructive Lung Disease in Northern Sweden Studies, Norrbotten County Council, Luleå, Sweden 
b Department of Respiratory Medicine and Allergology, Sunderby Central Hospital of Norrbotten, Luleå, Sweden 
c Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden 
d Department of Internal Medicine/Krefting Research Centre, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden 

Corresponding author: Eva Rönmark, PhD, Department of Public Health and Clinical Medicine, Occupational & Environmental Medicine, Umeå University, SE-901 87 Umeå, Sweden.

Abstract

Background

Prospective studies on the incidence and remission of allergic sensitization among adults are rare.

Objective

We sought to assess the incidence, remission, risk factors, and prevalence of allergic sensitization in relation to aging over a 10-year period.

Methods

In 1994, a sample of 664 adults (68% of invited) participated in clinical examinations, including a structured interview and skin prick tests (SPTs). The sample was randomly selected from a large questionnaire survey in Northern Sweden. In 2004, 555 subjects (93% of invited) were re-examined by using the same methods as in 1994. IgE levels were also measured in 2004.

Results

In 1994, the prevalence of any positive SPT response was significantly related to age, with the highest prevalence (55%) in subjects aged 20 to 29 years and the lowest prevalence (26%) in subjects aged 50 to 60 years. A similar age-related prevalence was found in 2004, and sensitization to pollen and pets was most common in both years. The results of the SPTs were verified by means of specific IgE measurement. The incidence of any positive SPT response was low. Only 9 subjects had any positive SPT response (ie, a cumulative incidence of 5% over 10 years). Remission was greater (ie, 32% over 10 years). The main risk factors for allergic sensitization were young age and a family history of allergy. Having had furred animals at home during childhood was negatively related to specific IgE levels.

Conclusion

The low incidence and high remission in adulthood explain the decreasing prevalence of allergic sensitization by age. Thus the low prevalence of allergic sensitization among the elderly found in cross-sectional studies is an effect of normal aging and not primarily a birth cohort effect.

El texto completo de este artículo está disponible en PDF.

Key words : Allergic sensitization, skin prick test, specific IgE, epidemiology, adults, incidence, remission, risk factors

Abbreviations used : ECRHS, OR, SPT


Esquema


 The studies were funded by the Swedish Heart-Lung Foundation, the Swedish Asthma-Allergy Foundation, Visare Norr and Umeå University, and the Swedish Research Council. Additional funding was provided by ALK-Abelló and Phadia.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 129 - N° 1

P. 136-142 - janvier 2012 Regresar al número
Artículo precedente Artículo precedente
  • Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
  • Gabriela Senti, Seraina von Moos, Fabian Tay, Nicole Graf, Theodor Sonderegger, Pål Johansen, Thomas M. Kündig
| Artículo siguiente Artículo siguiente
  • IL-10 controls dendritic cell–induced T-cell reactivation in the skin to limit contact hypersensitivity
  • Mathilde J.H. Girard-Madoux, Junda M. Kel, Boris Reizis, Björn E. Clausen

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.